Source: Eur Respir J 2001; 18: 246
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Affrime M.B., Banfield C., Nolop K.. Systemic bioavailability of inhaled corticosteroids: appropriate and comparable methodology. Eur Respir J 2001; 18: 246

Member's Comments

No comment yet.

Related content which might interest you: Systemic bioavailability of inhaled steroids: the importance of appropriate and comparable methodology Source: Eur Respir J 2001; 17: 157-158 Year: 2001 Integrating high dose inhaled corticosteroids into oral corticosteroids stewardship Source: Eur Respir J, 55 (1) 1902193; 10.1183/13993003.02193-2019 Year: 2020 Concomitant use of low-dose inhaled corticosteroids and a long-acting bronchodilatator visavi doubling the dose of inhaled corticosterod in asthma patients Source: Eur Respir J 2001; 18: Suppl. 33, 98s Year: 2001 Impact of the combination therapy: inhaled corticosteroid and long-acting beta agonists in the prescription pattern of inhaled corticosteroids Source: Annual Congress 2007 - Respiratory issues in primary care Year: 2007 Efficacy of systemic corticosteroids in refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β2 agonist inhalation Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2010 Oral steroid-sparing effect of high-dose inhaled corticosteroids in asthma Source: Eur Respir J, 55 (1) 1901147; 10.1183/13993003.01147-2019 Year: 2020 Asthma control in general practice with inhaled corticosteroids and long-acting B2-agonists administered as a fixed or free combination at stable dosage: the ALISE survey Source: Eur Respir J 2002; 20: Suppl. 38, 397s Year: 2002 Once per day inhaled corticosteroids: a method to improve compliance and asthma control Source: Eur Respir J 2001; 18: Suppl. 33, 441s Year: 2001 Systemic activity of two different dry powder combinations of inhaled corticosteroids and long-acting β2-agonists in children with asthma assessed by knemometry Source: Annual Congress 2012 - Assessing and treating childhood asthma and allergy Year: 2012 Step-up of asthma therapy: an observational study comparing increased inhaled corticosteroid dosage to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007 Treatment with inhaled corticosteroids (ICS) in patients with COPD: possible way of optimisation Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Asthma and once-daily administration of inhaled corticosteroids: potential for improved compliance and reduced health costs Source: Eur Respir J 2002; 20: Suppl. 38, 305s Year: 2002 Co-dispensing of inhaled corticosteroids and antibiotics Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012 Efficacy of low dose theophylline and inhaled corticosteroids in smokers with asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Reducing the dose of inhaled corticosteroids (ICS) under therapy with montelukast in stable asthma: effects on lung function and inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001 Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness Source: Eur Respir J 2006; 27: 1144-1151 Year: 2006 Patterns of adherence to inhaled corticosteroids Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019 Comparison of long-acting inhaled beta2–agonists plus inhaled steroids versus increasing dose of inhaled steroids on exhaled nitric oxide among asthmatic children poorly controlled Source: Eur Respir J 2005; 26: Suppl. 49, 617s Year: 2005 Inhaled corticosteroids in COPD: a case in favour Source: Eur Respir J 2009; 34: 10-12 Year: 2009